Background COVID-19 causes significant morbidity and mortality. Despite the high
prevalence of delirium and delirium-related symptoms in COVID-19 patients, data and …

Aim: To identify the nature of the evidence reporting hospital-based palliative and end-of-life
care during the COVID-19 pandemic. Background: The COVID-19 pandemic has seen an …

Seit Dezember 2019 verbreitet sich das neuartige Coronavirus SARS-CoV-2 (Severe Acute
Respiratory Syndrome–Corona Virus-2) rasch im Sinne einer weltweiten Pandemie. Dies …

Background: During the COVID-19 outbreak restricting measures may have affected the
provision of good end-of-life care for patients with and without COVID-19. Aim: To describe …

Background: COVID-19 has tragically resulted in over 2.5 million deaths globally. Despite
this, there is a lack of research on how to care for patients dying of COVID-19, specifically …

Background Descriptions of symptoms and medication use at end of life in COVID‐19 are
limited to small cross‐sectional studies, with no Australian longitudinal data. Aims To …

Background Psychiatric disorders increase risk of neuropsychiatric disease and poor
outcomes, yet little is known about the neuropsychiatric manifestations of COVID-19 in the …

Despite the increasing number of publications globally, the COVID-19 pandemic has
underscored significant research gaps that should be resolved, including within PC-related …

Abstract Background In March 2020, the outbreak caused by the SARS-CoV-2 virus was
declared a pandemic, resulting in numerous fatalities worldwide. To effectively combat the …

Background and Objectives: Descriptions of end-of-life in COVID-19 are limited to small
cross-sectional studies. We aimed to assess end-of-life care in inpatients with COVID-19 at …